Sandoz estradiol 25 mcg patches face critical supply shortage until October 30
Official source: Health Product Shortages Canada (opens in a new tab)
Healthcare news
News for British Columbia’s health workforce
Short briefs on what is changing in healthcare in British Columbia and across Canada, collected from official bodies and news outlets, each linked to its original source.
Check the original source before acting.
Sandoz reports critical shortage of 37.5 mcg estradiol patches until October 30
Official source: Health Product Shortages Canada (opens in a new tab)
Sandoz reports critical shortage of Estradot 75 mcg patches until December 18
Official source: Health Product Shortages Canada (opens in a new tab)
Sandoz reports upcoming Tier 3 shortage for Estalis hormone therapy patches
Official source: Health Product Shortages Canada (opens in a new tab)
Manitoba ends seasonal time changes affecting sleep patterns for health workers
News source: CBC News (opens in a new tab)
Calgary developed wound gel treats 6000 patients in Ukraine conflict
News source: CBC News (opens in a new tab)+1 more source
Roche to discontinue Activase 100 mg alteplase powder by January 2027
Official source: Health Product Shortages Canada (opens in a new tab)
Critical shortage of Stannous MDP imaging kits impacts bone scans until December
Official source: Health Product Shortages Canada (opens in a new tab)
Critical shortage of Stannous PYP imaging kits impacts Alberta nuclear medicine
Official source: Health Product Shortages Canada (opens in a new tab)
Janssen reports upcoming supply shortage for 6 mg Invega tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Janssen reports 9 mg Invega tablet shortage starting January 2027
Official source: Health Product Shortages Canada (opens in a new tab)
Software error in Siemens cardiac imaging systems causes inaccurate flow measurements
Official source: Health Canada recalls and alerts (opens in a new tab)
Siemens releases software update for Magnetom MRI scanners
Official source: Health Canada recalls and alerts (opens in a new tab)
BioMérieux reports false negative risks for specific BIOFIRE BCID2 panel lot
Official source: Health Canada recalls and alerts (opens in a new tab)
Teva Canada to stop manufacturing 25 mg Treanda doses by February 2027
Official source: Health Product Shortages Canada (opens in a new tab)
Teva to discontinue Treanda 100 mg chemotherapy drug on Feb 28, 2027
Official source: Health Product Shortages Canada (opens in a new tab)
AbbVie to discontinue Salofalk 4 g rectal suspension on Nov 4
Official source: Health Product Shortages Canada (opens in a new tab)
Cheplapharm reports critical Tier 3 shortage of 50 mg etoposide capsules
Official source: Health Product Shortages Canada (opens in a new tab)
Pfizer reports critical shortage of intravenous dextrose solution until February 15
Official source: Health Product Shortages Canada (opens in a new tab)
Formative Pharma reports upcoming supply shortage for 60 mg cabazitaxel injections
Official source: Health Product Shortages Canada (opens in a new tab)
Formative Pharma reports upcoming supply shortage for 45 mg cabazitaxel injections
Official source: Health Product Shortages Canada (opens in a new tab)
Baxter reports supply shortage of 4 mL Artiss fibrin sealant until March
Official source: Health Product Shortages Canada (opens in a new tab)
Sanofi reports supply shortage for 2.5 mg metolazone tablets until December 18
Official source: Health Product Shortages Canada (opens in a new tab)
Auro Pharma reports 100 mg ritonavir tablet shortage until December 15
Official source: Health Product Shortages Canada (opens in a new tab)
Hikma reports actual shortage of 1 g vancomycin injections until January 31
Official source: Health Product Shortages Canada (opens in a new tab)
Hikma reports 500 mg vancomycin injection shortage until January 31
Official source: Health Product Shortages Canada (opens in a new tab)
Roche reports Tamiflu oral suspension shortage until December 1 due to demand
Official source: Health Product Shortages Canada (opens in a new tab)
Novo Nordisk transitions 3 mg Rybelsus tablets to 1.5 mg formulation
Official source: Health Product Shortages Canada (opens in a new tab)
Omega Laboratories reports ongoing shortage of 0.4 mg naloxone injection
Official source: Health Product Shortages Canada (opens in a new tab)
Hikma reports shortage of intravenous levofloxacin solution until December 1
Official source: Health Product Shortages Canada (opens in a new tab)